The Release of Plasminogen Activator and Factor VIII after Injection of DDAVP in Healthy Volunteers and in Patients with von Willebrand's Disease
- 1 December 1980
- journal article
- Published by Wiley in Scandinavian Journal of Haematology
- Vol. 24 (5), 351-359
- https://doi.org/10.1111/j.1600-0609.1980.tb02749.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Measurement of Antihaemophilic Factor A Antigen (VIII:CAg) with a Solid Phase Immunoradiometric Method Based on Homologous Non‐Haemophilic AntibodiesScandinavian Journal of Haematology, 1979
- Specificity in the Factor VIII Response to Vasopressin Infusion in ManBritish Journal of Haematology, 1979
- DDAVP: Alternative zur Substitutionsbehandlung bei leichter Hämophilie A und von-Willebrand-Jürgens-SyndromDeutsche Medizinische Wochenschrift (1946), 1977
- D.D.A.V.P. IN HÆMOPHILIAThe Lancet, 1977
- 1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASEThe Lancet, 1977
- Immunoradiometric Assay of Factor VIII Related Antigen, with Observations in 32 Patients with von Willebrand's DiseaseBritish Journal of Haematology, 1976
- Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive DrugsBritish Journal of Haematology, 1975
- Synthesis of Antihemophilic Factor Antigen by Cultured Human Endothelial CellsJournal of Clinical Investigation, 1973
- Genetic Variants of von Willebrand's DiseaseBMJ, 1972
- On an Inherited Autosomal Hemorrhagic Diathesis with Antihemophilic Globulin (AHG) Deficiency and Prolonged Bleeding Times1Acta Medica Scandinavica, 1957